Adenosine Receptors as Targets for Therapeutic Intervention

Authors

  • B Suvarna Department of Pharmacology Melaka Manipal Medical College Manipal Campus, Manipal

DOI:

https://doi.org/10.3126/kumj.v11i1.11054

Keywords:

Adenosine, asthma, ischaemia/reperfusion injury, Parkinson’s disease, refractory primary pulmonary hypertension

Abstract

Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.

DOI: http://dx.doi.org/10.3126/kumj.v11i1.11054

Kathmandu University Medical Journal Vol.11(1) 2013: 96-101

Downloads

Download data is not yet available.
Abstract
696
PDF
648

Downloads

Published

2014-09-11

How to Cite

Suvarna, B. (2014). Adenosine Receptors as Targets for Therapeutic Intervention. Kathmandu University Medical Journal, 11(1), 96–101. https://doi.org/10.3126/kumj.v11i1.11054

Issue

Section

Review Articles